Request Sample Inquiry
Lung Cancer Therapeutics Market

Lung Cancer Therapeutics Market

Lung Cancer Therapeutics Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

210

Base Year:

2023

Date

Sep - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2568

Segments Covered
  • By Therapy By Therapy Radiation Therapy, Targeted Therapy, Immunotherapy, Chemotherapy, Others
  • By Lung Cancer Type By Lung Cancer Type Small Cell Lung Cancer, Non-small Cell Lung Cancer, Lung Carcinoid Tumor
  • By Distribution Channel By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
  • By Type of Molecule By Type of Molecule Small molecules, Biologics
  • By Drug Class By Drug Class Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multikinase Inhibitors, Others
  • By Region By Region North America , Europe , Asia Pacific , Latin America , The Middle-East and Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 29.1 Billion
Revenue 2032Revenue 2032: USD 63.7 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 9.1 %
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Lung Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Global Lung Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Global Lung Cancer Therapeutics Market - by Therapy
      1. By Radiation Therapy
      2. By Targeted Therapy
      3. By Immunotherapy
      4. By Chemotherapy
      5. By Others
    4. Global Lung Cancer Therapeutics Market - by Lung Cancer Type
      1. By Small Cell Lung Cancer
      2. By Non-small Cell Lung Cancer
      3. By Lung Carcinoid Tumor
    5. Global Lung Cancer Therapeutics Market - by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Global Lung Cancer Therapeutics Market - by Type of Molecule
      1. By Small molecules
      2. By Biologics
    7. Global Lung Cancer Therapeutics Market - by Drug Class
      1. By Alkylating Agents
      2. By Antimetabolites
      3. By EGFR Inhibitors
      4. By Mitotic Inhibitors
      5. By Multikinase Inhibitors
      6. By Others
    8. Global Lung Cancer Therapeutics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    9. Market comparative analysis
  4. North America Lung Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. North America Lung Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. North America Lung Cancer Therapeutics Market, by Therapy
      1. By Radiation Therapy
      2. By Targeted Therapy
      3. By Immunotherapy
      4. By Chemotherapy
      5. By Others
    4. North America Lung Cancer Therapeutics Market, by Lung Cancer Type
      1. By Small Cell Lung Cancer
      2. By Non-small Cell Lung Cancer
      3. By Lung Carcinoid Tumor
    5. North America Lung Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. North America Lung Cancer Therapeutics Market, by Type of Molecule
      1. By Small molecules
      2. By Biologics
    7. North America Lung Cancer Therapeutics Market, by Drug Class
      1. By Alkylating Agents
      2. By Antimetabolites
      3. By EGFR Inhibitors
      4. By Mitotic Inhibitors
      5. By Multikinase Inhibitors
      6. By Others
    8. North America Lung Cancer Therapeutics Market, by Country
      1. U.S.
        1. U.S. Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. U.S. Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. U.S. Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. U.S. Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. U.S. Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      2. Canada
        1. Canada Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Canada Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Canada Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Canada Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Canada Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      3. Mexico
        1. Mexico Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Mexico Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Mexico Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Mexico Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Mexico Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
  5. Europe Lung Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Europe Lung Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Europe Lung Cancer Therapeutics Market, by Therapy
      1. By Radiation Therapy
      2. By Targeted Therapy
      3. By Immunotherapy
      4. By Chemotherapy
      5. By Others
    4. Europe Lung Cancer Therapeutics Market, by Lung Cancer Type
      1. By Small Cell Lung Cancer
      2. By Non-small Cell Lung Cancer
      3. By Lung Carcinoid Tumor
    5. Europe Lung Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Europe Lung Cancer Therapeutics Market, by Type of Molecule
      1. By Small molecules
      2. By Biologics
    7. Europe Lung Cancer Therapeutics Market, by Drug Class
      1. By Alkylating Agents
      2. By Antimetabolites
      3. By EGFR Inhibitors
      4. By Mitotic Inhibitors
      5. By Multikinase Inhibitors
      6. By Others
    8. Europe Lung Cancer Therapeutics Market, by Country
      1. Germany
        1. Germany Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Germany Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Germany Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Germany Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Germany Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      2. UK
        1. UK Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. UK Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. UK Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. UK Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. UK Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      3. France
        1. France Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. France Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. France Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. France Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. France Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      4. Spain
        1. Spain Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Spain Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Spain Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Spain Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Spain Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      5. Italy
        1. Italy Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Italy Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Italy Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Italy Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Italy Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      6. BENELUX
        1. BENELUX Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. BENELUX Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. BENELUX Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. BENELUX Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. BENELUX Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      7. Rest of Europe
        1. Rest Of Europe Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Rest Of Europe Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Rest Of Europe Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Rest Of Europe Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Rest Of Europe Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
  6. Asia Pacific Lung Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Lung Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Lung Cancer Therapeutics Market, by Therapy
      1. By Radiation Therapy
      2. By Targeted Therapy
      3. By Immunotherapy
      4. By Chemotherapy
      5. By Others
    4. Asia Pacific Lung Cancer Therapeutics Market, by Lung Cancer Type
      1. By Small Cell Lung Cancer
      2. By Non-small Cell Lung Cancer
      3. By Lung Carcinoid Tumor
    5. Asia Pacific Lung Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Asia Pacific Lung Cancer Therapeutics Market, by Type of Molecule
      1. By Small molecules
      2. By Biologics
    7. Asia Pacific Lung Cancer Therapeutics Market, by Drug Class
      1. By Alkylating Agents
      2. By Antimetabolites
      3. By EGFR Inhibitors
      4. By Mitotic Inhibitors
      5. By Multikinase Inhibitors
      6. By Others
    8. Asia Pacific Lung Cancer Therapeutics Market, by Country
      1. China
        1. China Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. China Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. China Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. China Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. China Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      2. Japan
        1. Japan Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Japan Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Japan Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Japan Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Japan Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      3. India
        1. India Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. India Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. India Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. India Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. India Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      4. South Korea
        1. South Korea Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. South Korea Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. South Korea Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. South Korea Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. South Korea Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      5. South East Asia
        1. South East Asia Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. South East Asia Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. South East Asia Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. South East Asia Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. South East Asia Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Rest of Asia Pacific Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Rest of Asia Pacific Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Rest of Asia Pacific Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Rest of Asia Pacific Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
  7. Latin America Lung Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Latin America Lung Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Latin America Lung Cancer Therapeutics Market, by Therapy
      1. By Radiation Therapy
      2. By Targeted Therapy
      3. By Immunotherapy
      4. By Chemotherapy
      5. By Others
    4. Latin America Lung Cancer Therapeutics Market, by Lung Cancer Type
      1. By Small Cell Lung Cancer
      2. By Non-small Cell Lung Cancer
      3. By Lung Carcinoid Tumor
    5. Latin America Lung Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Latin America Lung Cancer Therapeutics Market, by Type of Molecule
      1. By Small molecules
      2. By Biologics
    7. Latin America Lung Cancer Therapeutics Market, by Drug Class
      1. By Alkylating Agents
      2. By Antimetabolites
      3. By EGFR Inhibitors
      4. By Mitotic Inhibitors
      5. By Multikinase Inhibitors
      6. By Others
    8. Latin America Lung Cancer Therapeutics Market, by Country
      1. Brazil
        1. Brazil Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Brazil Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Brazil Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Brazil Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Brazil Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      2. Argentina
        1. Argentina Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Argentina Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Argentina Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Argentina Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Argentina Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      3. Rest of Latin America
        1. Rest of Latin America Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Rest of Latin America Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Rest of Latin America Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Rest of Latin America Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Rest of Latin America Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
  8. Middle East & Africa Lung Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Lung Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Lung Cancer Therapeutics Market, by Therapy
      1. By Radiation Therapy
      2. By Targeted Therapy
      3. By Immunotherapy
      4. By Chemotherapy
      5. By Others
    4. Middle East & Africa Lung Cancer Therapeutics Market, by Lung Cancer Type
      1. By Small Cell Lung Cancer
      2. By Non-small Cell Lung Cancer
      3. By Lung Carcinoid Tumor
    5. Middle East & Africa Lung Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Middle East & Africa Lung Cancer Therapeutics Market, by Type of Molecule
      1. By Small molecules
      2. By Biologics
    7. Middle East & Africa Lung Cancer Therapeutics Market, by Drug Class
      1. By Alkylating Agents
      2. By Antimetabolites
      3. By EGFR Inhibitors
      4. By Mitotic Inhibitors
      5. By Multikinase Inhibitors
      6. By Others
    8. Middle East & Africa Lung Cancer Therapeutics Market, by Country
      1. GCC Countries
        1. GCC Countries Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. GCC Countries Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. GCC Countries Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. GCC Countries Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. GCC Countries Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      2. South Africa
        1. South Africa Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. South Africa Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. South Africa Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. South Africa Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. South Africa Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Lung Cancer Therapeutics Market, By Therapy
          1. By Radiation Therapy
          2. By Targeted Therapy
          3. By Immunotherapy
          4. By Chemotherapy
          5. By Others
        2. Rest of Middle East & Africa Lung Cancer Therapeutics Market, By Lung Cancer Type
          1. By Small Cell Lung Cancer
          2. By Non-small Cell Lung Cancer
          3. By Lung Carcinoid Tumor
        3. Rest of Middle East & Africa Lung Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
        4. Rest of Middle East & Africa Lung Cancer Therapeutics Market, By Type of Molecule
          1. By Small molecules
          2. By Biologics
        5. Rest of Middle East & Africa Lung Cancer Therapeutics Market, By Drug Class
          1. By Alkylating Agents
          2. By Antimetabolites
          3. By EGFR Inhibitors
          4. By Mitotic Inhibitors
          5. By Multikinase Inhibitors
          6. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. AstraZeneca PLC (UK)
    2. Boehringer Ingelheim International GmbH (Germany)
    3. Bristol Myers Squibb Company (U.S.)
    4. Eli Lilly and Company (U.S.)
    5. F. Hoffmann-La Roche Ltd. (Switzerland)
    6. Merck & Co. Inc. (U.S.)
    7. Pfizer Inc. (U.S.)
    8. Allergan Inc. (Ireland)
    9. Teva Pharmaceutical Industries Ltd. (Israel)
    10. Abbvie Inc. (U.S.)
    11. Johnson & Johnson (U.S.)
    12. Amgen Inc. (U.S.)
    13. Novartis AG (Switzerland)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Lung Cancer Therapeutics valued at USD 29.1 Billion in 2023 and is expected to reach USD 63.7 Billion in 2032 growing at a CAGR of 9.1 %.

  • The prominent players in the market are AstraZeneca PLC (UK), Boehringer Ingelheim International GmbH (Germany), Bristol Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Allergan Inc. (Ireland), Teva Pharmaceutical Industries Ltd. (Israel), Abbvie Inc. (U.S.), Johnson & Johnson (U.S.), Amgen Inc. (U.S.), Novartis AG (Switzerland).

  • The market is project to grow at a CAGR of 9.1 % between 2024 and 2032.

  • The driving factors of the Lung Cancer Therapeutics include

  • North America was the leading regional segment of the Lung Cancer Therapeutics in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy